← Evidence map

ArticleResearch square2021

Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19).

Marvin R McCreary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19). | OpenQuestion